Forte Biosciences Inc (FBRX) concluded trading on Wednesday at a closing price of $13.55, with 29.51 million shares of worth about $399.82 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -9.67% during that period and on November 20, 2024 the price saw a gain of about 128.69%. Currently the company’s common shares owned by public are about 1.45M shares, out of which, 1.22M shares are available for trading.
Stock saw a price change of 138.98% in past 5 days and over the past one month there was a price change of 185.26%. Year-to-date (YTD), FBRX shares are showing a performance of -34.04% which increased to 11.16% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $4.11 but also hit the highest price of $21.25 during that period. The average intraday trading volume for Forte Biosciences Inc shares is 11.91K. The stock is currently trading 148.02% above its 20-day simple moving average (SMA20), while that difference is up 143.14% for SMA50 and it goes to 9.11% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Forte Biosciences Inc (NASDAQ: FBRX) currently have 1.45M outstanding shares and institutions hold larger chunk of about 53.94% of that.
The stock has a current market capitalization of $19.80M and its 3Y-monthly beta is at 0.07. It has posted earnings per share of -$19.39 in the same period. It has Quick Ratio of 2.06 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for FBRX, volatility over the week remained 28.96% while standing at 12.81% over the month.
Stock’s fiscal year EPS is expected to rise by 35.51% while it is estimated to increase by 76.40% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Ladenburg Thalmann on April 08, 2024 offering a Buy rating for the stock and assigned a target price of $2.75 to it. Coverage by Chardan Capital Markets stated Forte Biosciences Inc (FBRX) stock as a Buy in their note to investors on September 20, 2021, suggesting a price target of $3.50 for the stock. Stock get a Sell rating from Chardan Capital Markets on September 03, 2021.
